Porphyromonas gingivalis is one of the major pathogens of periodontitis, a condition characterized by excessive alveolar bone resorption by osteoclasts. The bacterium produces cysteine proteases called gingipains, which are classified according to their cleavage-site specificity into Kgps (lysine-specific gingipains) and Rgps (arginine-specific gingipains). In the present study we examined the effects of gingipains on osteoclast differentiation. In co-cultures of mouse bone-marrow cells and osteoblasts, formation of multinucleated osteoclasts induced by 1α,25(OH) 2 D 3 (1α,25-dihydroxyvitamin D 3 ) was augmented by Kgp but not by RgpB. A physiological concentration (0.1 nM) of 1α,25(OH) 2 D 3 induced the osteoclast formation in the presence of 100 nM Kgp to an extent comparable with that induced by 10 nM 1α,25(OH) 2 D 3 . Kgp also enhanced osteoclastogenesis induced by various microbial components, including lipopolysaccharide. Combined use of Kgp and 1α,25(OH) 2 D 3 or lipopolysaccharide also increased the number of resorption pits developed on dentin slices, indicating that the osteoclasts formed in the presence of Kgp possess bone-resorbing activity. The enhanced osteoclastogenesis by Kgp was correlated with a depletion of osteoprotegerin in co-culture medium and was proteolytic-activity-dependent, since benzyloxycarbonyl-L-phenylalanyl-L-lysylacycloxyketone, an inhibitor of Kgp, completely abolished osteoclastogenesis induced by Kgp. Kgp digested osteoprotegerin, since its recombinant protein was susceptible to degradation by Kgp in the presence of serum. As a result, Kgp did not augment osteoclastogenesis in co-cultures of osteoprotegerin-deficient osteoblasts and bonemarrow cells. In addition, enhanced osteoclastogenesis by Kgp was abolished by an excess amount of recombinant osteoprotegerin. These findings suggest that degradation of osteoprotegerin is one of the mechanisms underlying promotion of osteoclastogenesis by Kgp.
INTRODUCTION
Periodontitis is a chronic inflammatory disease accompanied by a decrease in alveolar bone volume due to excessive bone resorption by osteoclasts. Osteoclasts are multinucleated giant cells differentiated from monocyte/macrophage lineage cells by cell-cell interactions with osteoblasts. Osteoblasts produce key factors, such as RANKL {RANK [receptor activator of NF-κB (nuclear factor κB)] ligand} and OPG (osteoprotegerin), which regulate osteoclast differentiation [1, 2] . RANKL is a membrane-associated factor that induces osteoclast differentiation by activating intracellular signals mediated via RANK expressed on the plasma membrane of osteoclast precursors [3, 4] . In contrast, OPG is a soluble-form decoy receptor for RANKL that inhibits osteoclast differentiation by interrupting RANKL-RANK binding [5, 6] . Thus the balance between the expression level of RANKL and that of OPG in osteoblasts is critical for regulation of osteoclastogenesis and control of bone mineral density.
RANKL expression in osteoblasts is induced by bone-resorbing factors such as 1α,25(OH) 2 D 3 (1α,25-dihydroxyvitamin D 3 ) and parathyroid hormone under physiological conditions. However, in pathological situations, including periodontitis, compounds derived from bacteria, such as LPS (lipopolysaccharide), a cellwall constituent of Gram-negative bacteria, as well as lipoteichoic acid and PGN (peptidoglycan), have been reported to be the major factors that facilitate osteoclastogenesis [7] [8] [9] . LPS and other bacterial components, including PGN and CpG DNA, are recognized by TLRs (Toll-like receptors), which are widely expressed in various kinds of cells [10, 11] . Among the bacteria found in subgingival microflora, Porphyromonas gingivalis has been proposed to be a potent aetiological agent of periodontitis.
P. gingivalis secretes cysteine proteases called gingipains, and it is known that more than 85 % of the proteolytic activity derived from this bacterium is attributed to them [12] . Gingipains are the products of three independent genes, namely, rgpA, rgpB and kgp, and the bacterium produces several proteins from these genes, including RgpA (cat) , HRgpA, mt (membrane type)-RgpA, RgpB, mt-RgpB, Kgp and mt-Kgp, which are bacterial cell-surfaceassociated variants of proteases. These proteases are referred to as Rgps (arginine-specific gingipains) and Kgps (lysinespecific gingipains), depending on the specificity for hydrolysis of either the Arg-Xaa or Lys-Xaa peptide bond respectively [12] . Rgps are known to activate the kinin-kallikrein system, the bloodcoagulation system and protease-activated receptors on platelets [13] , whereas Kgps reportedly degrade fibrinogen/fibrin [14] .
Gingipains destroy matrix components directly and indirectly
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by stimulating the expression and secretion of MMPs (matrix metalloproteases) [15] and also degrade several cytokines, components of complement systems and receptors on immune cells [16] [17] [18] [19] . All of these activities of gingipains are considered to be involved in the progression of periodontitis. In addition to these host-degenerative actions, it has been reported that immunization with gingipains protected P. gingivalisinduced periodontal bone loss in rats [20] . In addition, RANKL expression in mouse osteoblasts was observed in vitro following infection with wild-type P. gingivalis, but not after infection with a gingipain-deficient mutant [21] . Furthermore, involvement of gingipains in alveolar bone loss was suggested in a murine periodontitis model by using P. gingivalis mutants deficient of gingipains, in which the relative contribution of each gingipain in bone destruction was shown to be Kgp > RgpB > HRgpA [22] . These observations indicate that gingipains are involved not only in soft-tissue destruction and inflammation, but also in osteoclastogenesis and osteoclast-dependent bone resorption associated with periodontitis.
Despite what is known about gingipains, the precise mechanisms underlying their promotion of osteoclastic bone resorption have not been elucidated. In the present study we found that Kgp degrades OPG and thereby augments osteoclast differentiation in the co-culture of bone-marrow cells and osteoblasts induced by physiological and pathological bone-resorbing factors, namely, 1α,25(OH) 2 D 3 and various microbial components. These results provide new insights into the treatment and prevention of bone loss associated with periodontitis.
EXPERIMENTAL

Reagents
LPS from Escherichia coli (O55:B5) and PGN from Staphylococcus aureus were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Poly(I:C) RNA was from GE Healthcare BioScience Co. (Piscataway, NJ, U.S.A.). LPS from P. gingivalis W83 was prepared in our laboratories. Phosphothioate-stabilized CpG DNA (TCCATGACGTTCCTGATGCT) was kindly donated by Dr Y. Choi (University of Pennsylvania School of Medicine, Philadelphia, PA, U.S.A.), 1α,25(OH) 2 D 3 and Leucoprol (recombinant human macrophage colony-stimulating factor) were obtained from Wako Pure Chemical Industries Ltd (Osaka, Japan) and Kyowa Hakko Kogyo (Tokyo, Japan) respectively. Recombinant human OPG and the monoclonal antibody for human OPG were obtained from R&D Systems Inc. (Minneapolis, MN, U.S.A.). Z-FK-ck (benzyloxycarbonyl-L-phenylalanyl-L-lysylacyloxyketone) was purchased from Bachem (King of Prussia, PA, U.S.A.) [23] . The CellTiter 96 Aqueous One Solution Cell Proliferation Assay was from Promega (Madison, WI, U.S.A.).
Gingipains
Two types of gingipains, 105-kDa Kgp and 50-kDa RgpB, were purified from the culture supernatant of P. gingivalis HG66, as described by Pike et al. [24] , then incubated for 5 min at 37
• C with 10 mM cysteine in 0.2 M Hepes buffer, pH 8.0, containing 10 mM CaCl 2 before use to re-activate the proteases by reducing the active-centre thiol group partially oxidized during the purification process. To block the enzyme activity of Kgp, re-activated Kgp was further incubated for 30 min with 0.1 mM Z-FK-ck, which titrates the active centre of Kgp. The activated and inactivated gingipains were then diluted with the appropriate medium or buffer [19] .
Cell cultures
Newborn and 6-week-old ddY mice were purchased from Sankyo Labo Service Co. Inc. (Tokyo, Japan). Primary osteoblasts were isolated from the calvaria of newborn mice using a conventional method with collagenase and dispase, as previously described [25] . Bone-marrow cells were obtained from the femurs and tibiae of 6-week-old mice. Isolation of osteoblasts and bonemarrow cells from mice was performed according to the protocol approved by the Ethical Board for Animal Experiments at Showa University. Osteoclasts were generated in co-cultures of bonemarrow cells and primary osteoblasts as described previously [25] . In brief, cells were cultured in α-MEM (α-minimal essential medium) supplemented with 10 % (v/v) FBS (fetal bovine serum) and various concentrations of 1α,25(OH) 2 D 3 or LPS in culture plates at 37
• C under CO 2 /air (1:19). The medium was replaced every 3 days with fresh medium containing the same concentrations of 1α,25(OH) 2 D 3 or LPS. Osteoclast generation was evaluated by determining the enzymatic activity of TRAP (tartrate-resistant acid phosphatase), a marker enzyme of osteoclasts or by counting TRAP-positive multinucleated cells with three or more nuclei.
Pit-formation assay
Osteoblasts (2 × 10 4 cells) and bone-marrow cells (2 × 10 5 cells) were co-cultured for 1 h to allow attachment on dentin slices (4 mm in diameter and 0.2 mm in thickness) in 96-well culture plates as described above. The dentin slices with osteoblasts and bone-marrow cells were then transferred to 48-well culture plates and further incubated for 6 days in the presence of various concentrations of 1α,25(OH) 2 D 3 or LPS. After wiping off the cells with cotton cloth, the dentin slices were immersed in Toluidine Blue O (Sigma-Aldrich) to stain resorption pits formed by mature osteoclasts. The numbers of resorption pits on the dentin slices were counted under a microscope.
Immunoblot analysis
For detection of proteolysis of OPG by Kgp or RgpB in a cell-free system, the recombinant human OPG (5 μg/ml) was separately incubated with 0, 5 or 100 nM Kgp or RgpB at 37
• C in Hanks balanced salt solution or in α-MEM containing 10 % (v/v) FBS. Products of the cell-free reactions were separated by SDS/10%-(w/v)-PAGE under reducing conditions and electro-transferred on to Immobilon-P membranes (Millipore, Billerica, MA, U.S.A.). The membranes were blocked with 3 % non-fat dried skimmed milk powder in 20 mM Tris/HCl (pH 7.4) containing 150 mM NaCl and 0.1 % Tween 20, and subjected to immunoblotting with the antibody against OPG, followed by incubation with the secondary antibody conjugated to horseradish peroxidase. Secondary antibody was detected using an ECL ® detection kit (GE Healthcare Bio-Science, Piscataway, NJ, U.S.A.).
Quantification of OPG
The amount of OPG in the co-culture medium was quantified using a mouse OPG/TNFRSF11B Immunoassay kit (R&D Systems) according to the manufacturer's instructions.
Osteoclast differentiation in co-cultured cells from OPGdeficient mice
Osteoblasts and bone-marrow cells were isolated as described above from 6-week-old OPG-deficient C57BL/6 mice obtained from Clea Japan Inc. (Tokyo, Japan). The OPG-deficient osteoblasts and bone-marrow cells were co-cultured in the presence or absence of 1 ng/ml LPS from E. coli or P. gingivalis and 100 nM Kgp for 5 days, after which TRAP-positive cells with three or more nuclei were counted as osteoclasts.
Statistical analysis
Data are expressed as means + − S.D. Student's t test was used for statistical analyses, with P values < 0.05 considered significant.
RESULTS
Kgp enhanced osteoclast formation induced by 1α,25(OH) 2 D 3
We examined the effects of Kgp on osteoclast formation using a classical culture system in which bone-marrow cells and osteoblasts were co-cultured in the presence of 1α,25(OH) 2 D 3 . In the absence of Kgp, 1α,25(OH) 2 D 3 at 0.1 nM did not induce the formation of TRAP-positive multinucleated osteoclasts, whereas the presence of Kgp with 1α,25(OH) 2 D 3 enhanced formation in a concentration-dependent manner ( Figure 1A ). Furthermore, a small number of osteoclasts appeared in the culture with 100 nM Kgp in the absence of 1α,25(OH) 2 D 3 . Also, the number of osteoclasts was increased by the addition of 1α,25(OH) 2 D 3 as compared with the control in a dose-dependent manner, which was reflected in TRAP activity ( Figure 1B) . We also examined whether the effects of Kgp on bone resorption coincided with osteoclast formation. As in the case of osteoclast formation, the number of resorption pits formed in the presence of 100 nM Kgp was significantly greater than that formed in the absence of Kgp (Figures 1C and 1D ).
Kgp enhanced osteoclast formation in the presence of microbial constituents
Since Kgp is produced by P. gingivalis, a Gram-negative bacterium, we examined the effects of Kgp and microbial constituents, such as LPS, PGN, unmethylated CpG DNA and poly(I:C) RNA, on osteoclast formation in co-cultures of osteoblasts and bone-marrow cells. In the absence of Kgp, LPS from E. coli at a concentration of 10 ng/ml or lower did not induce the formation of multinucleated osteoclasts, as only mononuclear osteoclasts or osteoclast precursors appeared (Figures 2A and 2B ). In contrast, E. coli LPS induced osteoclast formation in a dose-dependent manner in the presence of 100 nM Kgp (Figures 2A and 2B) , as was observed in the culture with Kgp plus 1α,25(OH) 2 D 3 ( Figure 1B ). Resorption pits were formed in the presence of both E. coli LPS and Kgp, but not in the presence of LPS alone ( Figures 2C and 2D ). While LPS from P. gingivalis at 1 ng/ml significantly fostered the osteoclast differentiation in the presence of 100 nM Kgp, its ability to promote osteoclastogenesis seemed weaker than that from E. coli ( Figure 2E ). The higher concentration of P. gingivalis LPS up to 100 ng/ml rather suppressed osteoclast differentiation. In addition to LPS from E. coli and P. gingivalis, other microbial constituents, such as unmethylated CpG DNA, PGN and poly(I:C) RNA, also induced osteoclast formation exclusively in the presence of Kgp ( Figure 2F ).
The enzymatic activity of Kgp is involved in osteoclast formation
To examine whether the specific enzymatic activity of Kgp is necessary for osteoclast formation, RgpB, an arginine-specific gingipain produced by P. gingivalis, was added to co-cultures supplemented with a low concentration of 1α,25(OH) 2 D 3 (0.1 nM) or LPS from E. coli (1 ng/ml). In contrast with Kgp, RgpB (100 nM) did not induce osteoclast formation in the co-cultures of osteoblasts and bone-marrow cells, even in the presence of 1α,25(OH) 2 D 3 and LPS from E. coli ( Figure 3A) . To elucidate the involvement of the proteolytic activity of Kgp in the augmented osteoclastogenesis, the effect of Z-FK-ck, a catalytic-centretitrating inhibitor for Kgp, was examined in the co-culture system. Z-FK-ck at a concentration 2.5-fold higher than that used in the co-culture system did not affect either the viability of mouse osteoblasts ( Figure 3B ) or the osteoclast formation induced by 1α,25(OH) 2 D 3 in the co-culture of mouse osteoblasts and bonemarrow cells ( Figure 3C ). The same concentration of Z-FK-ck had no effect on the differentiation of mouse osteoclasts from bone-marrow macrophages induced by RANKL (results not shown). Therefore Kgp with the catalytic cysteine residue covalently modified by Z-FK-ck was used in an osteoclast formation assay. Osteoclasts did not appear in the co-cultures to which pre-inactivated Kgp was added along with E. coli LPS Figure 3D ). These results suggest that the proteolytic activity of Kgp is crucial for the induction of osteoclast formation by Kgp.
Kgp degraded OPG
To reveal the mechanism by which Kgp augments osteoclastogenesis, we examined the proteolysis of recombinant human OPG by Kgp. Kgp at 5 nM degraded 25 μg/ml OPG in Hanks balanced salt solution in a time-dependent manner ( Figure 4A ). Kgp at 5 nM partially, and that at 100 nM completely, cleaved 25 μg/ml OPG at least into five fragments in 15 h in α-MEM containing 10 % FBS, whereas the same concentration of RgpB did not ( Figure 4B ). These results suggested that the enhancement of osteoclastogenesis by Kgp was at least in part via the proteolytic degradation of OPG by Kgp.
We then quantified OPG in the co-culture medium in the presence or absence of Kgp and LPS from E. coli. E. coli LPS at 1 ng/ml suppressed the secretion of OPG by osteoblasts in the coculture system ( Figure 4C ). Regardless of whether LPS is present or not, 100 nM Kgp significantly decreased the concentration of OPG in the culture supernatants ( Figure 4C ), a finding consistent with the degradation of recombinant OPG by Kgp in a cell-free reaction environment (Figures 4A and 4B ).
Kgp did not enhance LPS-induced osteoclast formation in co-culture of OPG-deficient cells.
To ascertain whether the degradation of OPG by Kgp causes enhancement of osteoclast formation, we examined the effect of Kgp on osteoclast formation in a co-culture of OPGdeficient osteoblasts and bone-marrow cells. A small number of Figures 5A and 5B) . Although a lot of mononuclear, TRAP-positive cells were formed without any stimulation in OPG-deficient co-cultures, they were not counted as osteoclasts. LPS from E. coli at 1 ng/ml significantly increased the number of multinuclear osteoclasts. Kgp at 100 nM, however, did not affect osteoclast formation, either in the absence or presence of E. coli LPS ( Figure 5A ). LPS from P. gingivalis was less potent than that from E. coli in inducing osteoclast differentiation in the OPG-deficient co-culture. Kgp again did not promote osteoclast differentiation in the OPG-deficient coculture, in either the presence or absence of P. gingivalis LPS ( Figure 5B ). In addition, osteoclast differentiation induced by 1 ng/ml LPS from E. coli and 100 nM Kgp in the co-culture of wild-type osteoblasts and bone-marrow cells was inhibited to the level obtained in the absence of Kgp by human recombinant OPG in a concentration-dependent manner ( Figure 5C ). Therefore it is plausible that one of the major targets of Kgp is OPG and that the degradation of OPG by Kgp promotes osteoclastogenesis, even if other mechanisms still remain unexplained.
DISCUSSION
It has been reported that LPS derived from bacteria colonized in periodontal tissue is critically involved in bone loss associated with periodontitis [9, 26] , and it was also shown that osteoblasts play a crucial role in LPS-induced bone loss [9] . LPS stimulates the expression of RANKL and down-regulates that of OPG in osteoblasts [8] , which causes the promotion of osteoclast differentiation. On the other hand, it has been reported that microbial components, including LPS, inhibit osteoclast differentiation via stimulation of TLRs distributed on osteoclast precursor cells [27] . Therefore it remains controversial whether LPS is the sole factor crucial for osteoclast-dependent bone resorption in periodontitis.
In the present study we found that Kgp facilitated osteoclast differentiation induced by 1α,25(OH) 2 D 3 and LPS in a co-culture system. More specifically, in the presence of 100 nM Kgp, a physiological concentration (0.1 nM) of 1α,25(OH) 2 D 3 induced the differentiation and activation of osteoclasts (Figure 1) . Osteoclast differentiation and pit formation were also observed in co-cultures in medium containing 1 ng/ml LPS from E. coli and 100 nM Kgp (Figures 2A-2D ). The concentrations of 1α,25(OH) 2 D 3 and E. coli LPS required for osteoclastogenesis in the presence of Kgp were 100-fold lower than those required in the absence of this gingipain. Enhanced formation of osteoclasts was also observed in the co-culture with LPS from P. gingivalis at 1 ng/ml and 100 nM Kgp, even though the effect of P. gingivalis LPS was less potent than that of E. coli LPS at the same concentration ( Figure 2E ). Furthermore, Kgp in the present co-culture systems also enhanced osteoclast differentiation induced by other microbial components, such as unmethylated CpG DNA, PGN and poly(I:C) RNA ( Figure 2F ). It is known that 1α,25(OH) 2 D 3 , E. coli LPS, unmethylated CpG DNA and PGN induce the expression of RANKL in osteoblasts via activation of the vitamin D receptor, TLR-4, TLR-9 and nucleotide-binding oligomerization domain 2 pathways respectively [2, 8, 28, 29] . However, although it is known that poly(I:C) RNA is a ligand for TLR-3, to the best of our knowledge, induction of RANKL expression or osteoclast formation by poly(I:C) RNA has not been reported. Our findings that Kgp enhanced the osteoclast-inducing activity of various compounds with different signalling pathways suggest that it has an effect on some process other than the induction of RANKL expression in osteoblasts by these compounds.
The stimulatory effects of Kgp on osteoclastogenesis in the presence of 1α,25(OH) 2 D 3 and E. coli LPS in the co-culture system were dependent on the protease activity of Kgp. A small number of osteoclasts were formed after incubation with active Kgp even in the absence of 1α,25(OH) 2 D 3 or E. coli LPS, and that effect was completely inhibited by Z-FK-ck ( Figure 3D ). The results shown in Figure 4 strongly indicate that the proteolytic elimination of OPG from the culture medium by Kgp is one of the major mechanisms of enhanced osteoclast formation in the presence of Kgp. This hypothesis is supported by the results obtained in the co-culture of cells from OPG-deficient mice, where Kgp did not promote osteoclast formation (Figures 5A and 5B) . On the other hand, addition of excess amount of recombinant OPG suppressed osteoclast differentiation induced by E. coli LPS and Kgp ( Figure 5C ), which again reinforced this hypothesis. These results, however, do not exclude other possible mechanisms responsible for the Kgp-dependent osteoclast differentiation. Kgp also induced osteoclastogenesis in the absence of bone-resorbing factors such as 1α,25(OH) 2 D 3 and microbial components, even though its efficacy was much lower than that used in the combination with these factors (Figures 1 and 2) . It was previously reported that the expression of RANKL was induced in the osteoblasts by wild-type P. gingivalis via protease-activated receptors, but not by the gingipain-deficient mutants [21] . The role of gingipains in osteoclastogenesis, other than degradation of OPG, remains to be explored.
Various bacteria constitute the microflora in the human gingival crevice. In the animal models of periodontitis, the mixed infection of several bacteria, including P. gingivalis, induced the severer alveolar bone loss compared with infection by P. gingivalis alone [30, 31] . Therefore it is plausible that the potentiation by Kgp of osteoclastogenesis in the presence of various microbial components (Figure 2 ) underlies the alveolar bone loss associated with periodontitis.
Unlike LPS from E. coli, that from P. gingivalis is a ligand for TLR-2 [32] . The contribution of TLR-2 was observed in the tumour-necrosis-factor-α-dependent/RANKL-independent osteoclastogenesis in response to P. gingivalis infection [33] . It was also reported that LPS from P. gingivalis induced the expression of RANKL in cementoblasts via TLR-2 [34] . On the other hand, a contribution of TLR-2 in the osteoclast differentiation induced by muramyl dipeptide, the minimal essential unit of PGN, in the mouse co-culture system, was ruled out [29] . The less potent activity of LPS from P. gingivalis in promoting osteoclast differentiation in the presence of Kgp in comparison with those of the other ligands of the TLR families, such as E. coli LPS (TLR-4), unmethylated CpG DNA (TLR-9) and poly(I:C) RNA (TLR-3), suggests that TLR-2 makes a minor contribution to the induction of osteoclast differentiation in the co-culture system we employed in the present study ( Figure 2 ). Further investigation is required to elucidate the role of P. gingivalis LPS and/or TLR-2 in the osteoclastogenesis in the co-culture of osteoblasts and osteoclast precursor cells.
One of the important findings of the present study is that Kgp enhances the decalcifying activity of osteoclasts as well as their differentiation induced by the combined use of a low concentration of either 1α,25(OH) 2 D 3 or LPS from E. coli. Even in the absence of 1α,25(OH) 2 D 3 or LPS, a small number of osteoclasts formed by incubation with 100 nM Kgp yielded resorption pits on dentin slices ( Figures 1C and 2C) . A physiological concentration of 1α,25(OH) 2 D 3 (0.1 nM) or E. coli LPS at 1 ng/ml or lower dramatically elevated the number of resorption pits formed in the presence of 100 nM Kgp ( Figures 1C, 1D, 2C and 2D), indicating that Kgp is able to support osteoclastic bone resorption in vivo in P. gingivalis-infected periodontitis sites. It has been reported that Kgp activates pro-MMP-1 and pro-MMP-9 by limited proteolysis [35] . Along with elimination of the inhibitory effects of OPG due to its degradation by Kgp, it is possible that Kgp is involved in the formation of resorption pits on dentin slices by direct hydrolysis of dentin matrix components or by activating pro-MMPs secreted by osteoclasts.
In contrast with Kgp, RgpB did not have an effect on osteoclast differentiation in the same experimental settings ( Figure 3A) , which could be explained by poor degradation of OPG in the presence of 10 % FBS ( Figure 4B ). Since OPG was fragmented after incubation with RgpB in the buffer without serum (results not shown), protease inhibitors in the serum likely suppressed the protease activity of RgpB. It has been reported that Rgps, but not Kgp, were inhibited by α2-macroglobulin in human plasma [12, 36] and it is possible that inhibitors in bovine serum, such as α 2 -macroglobulin, effectively inhibit RgpB, whereas they do not suppress the proteolytic activity of Kgp. Therefore the contrasting activities of RgpB and Kgp in enhancing osteoclastogenesis in the presence of 1α,25(OH) 2 D 3 or LPS in the present co-culture systems might have been the result of different levels of inhibition of these proteases by serum protease inhibitors, although other mechanisms cannot be excluded. A recent study by Pathirana et al. [22] , who used gingipain-deficient mutants of P. gingivalis, indicated that gingipains were involved in the induction of alveolar bone loss in a murine periodontitis model. Interestingly, the activity of Kgp was found to contribute more significantly to bone loss than did other gingipains. Their findings are consistent with the present study and can be explained, at least in part, by enhanced osteoclastogenesis by Kgp in combination with other bacterial components.
In the present study we found that Kgp and bone-resorbing factors such as 1α,25(OH) 2 D 3 , LPS and other bacterial components synergistically induce osteoclast differentiation and function in a setting where both osteoblasts and osteoclast precursor cells co-exist. Although LPS released from periodontal bacteria has been regarded as the major factor for osteoclastogenesis and alveolar bone loss in periodontitis, these findings reveal that Kgp is another factor involved those associated with P. gingivalis infection. Our observations also suggest targeted nullification of Kgp activity as a possible strategy for treatment and/or prevention of bone loss in patients affected by periodontitis.
